Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

Medtronic plc MDT has secured FDA approval for the Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures. The clearance provides U.S. surgeons and the health system with a ...

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the Hugo robotic-assisted surgery (RAS) ...

FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

Rome Health is expanding its robotic surgery program to provide men with a new minimally invasive option to treat an enlarged ...

The Business Research Company's Urology Robotic Surgery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report Explores Market ...

Please provide your email address to receive an email when new articles are posted on . The most effective and preferred treatment for many cancers remains surgery, and surgical techniques continue to ...

A single-institution study found no significant increase in the risk for complications or readmissions between patients who underwent robotic urologic surgery before and during the COVID-19 pandemic.

Aster DM Healthcare is transforming surgical care in India by integrating robotic-assisted procedures across urology, ...

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...